Company Search:
Advanced Search
Sponsored Links
Mymetics Corporation Company Snapshot
Mymetics Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mymetics with three other companies in this sector in the United States: Asterias Biotherapeutics Inc (2015 sales of $3.58 million of which 100% was Regenerative Medicine), Fate Therapeutics Inc ($2.43 million of which 100% was Biopharmaceuticals), and Protalix Biotherapeutics Inc ($4.36 million of which 100% was Biotherapeutic Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mymetics Corporation
  Stock Performance Chart for Mymetics Corporation
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .01
(Figures in U.S. Dollars)
1 Week -10.3%   13 Weeks -18.8%  
4 Weeks -12.8%   52 Weeks -35.0%  
Mymetics Corporation Key Data:
  Ticker: MYMX Country: Switzerland
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 3,478,704
(Year Ending Jan 2016).
Employees: 8
  Currency: U.S. Dollars Market Cap: 3,948,849
  Fiscal Yr Ends: December Shares Outstanding: 303,757,622
  Share Type: Common Closely Held Shares: 164,776,459
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.